RIS-Page 13
The department worked with multiple stakeholders at the Michigan Board of Pharmacy Rules Committee Work
Group meetings, that included members from the Board of Pharmacy, educational institutions, businesses, and other
members of the public in the development of the proposed rules. The board is composed of members of the
profession and public members who work in businesses in Michigan.
A. If small businesses were involved in the development of the rules, please identify the business(es).
Representatives from businesses were involved in the development of the rules. However, the department is not
aware if they meet the definition of a “small business.”
Cost-Benefit Analysis of Rules (independent of statutory impact)
28. Estimate the actual statewide compliance costs of the rule amendments on businesses or groups.
The department does not expect any statewide compliance costs of the proposed rules on businesses or groups other
than the costs for a pharmacy should it take advantage of the new rule that allows a pharmacy to place an automated
device outside of a pharmacy or add a non-dispensing storage and pick up device on the premises of a pharmacy. Any
pharmacy that dispenses drugs should already have a sink with running water, a refrigerator, and a telephone.
A. Identify the businesses or groups who will be directly affected by, bear the cost of, or directly benefit from the
proposed rules.
There are approximately 3,540 pharmacies, 559 manufacturers, 1,827 wholesale distributors, 2 wholesale distributor-
brokers, and 7 remote pharmacies in Michigan that may be considered small businesses depending on their size and
annual sales. The proposed rules will impact businesses or groups as follows: businesses that are required to be
inspected under the rules will have their company information protected; a business that is required to maintain a PIC
or facility manager must ensure that the PIC or facility manager is not absent and unable to fulfill their duties for 120
consecutive days; an out-of-state pharmacy that will not compound sterile pharmaceutical products in this state may
submit an inspection from NABP-VPP or a resident state board of pharmacy which makes meeting the regulations
easier; an in-state pharmacy that will compound sterile pharmaceutical products will have a two-step inspection
process that requires an inspection from the department and within 6 months an inspection to assess USP compliance
or accreditation instead of attempting to show compliance with USP before being licensed which makes meeting the
regulation easier on the pharmacy; a pharmacy that dispenses drugs will have a sink with running water, a
refrigerator for drugs, and a telephone if it does not currently have these items; a manufacturer will have the option of
submitting an inspection from the FDA, the manufacturer’s resident state board of pharmacy, or NABP drug
distributor accreditation which gives options to the manufacturer; a pharmacy, should it take advantage of the new
rule that allows a pharmacy to place an automated device outside of a pharmacy or add a non-dispensing storage and
pick up device on the premises of a pharmacy, will have additional costs and additional benefits.
B. What additional costs will be imposed on businesses and other groups as a result of these proposed rules (i.e.
new equipment, supplies, labor, accounting, or recordkeeping)? Please identify the types and number of businesses
and groups. Be sure to quantify how each entity will be affected.
The department does not expect the proposed rules to result in any other additional costs such as new equipment,
supplies, labor, accounting, or recordkeeping on businesses or other groups unless a pharmacy takes advantage of the
new rule that allows a pharmacy to place an automated device outside of a pharmacy, add a non-dispensing storage
and pick up device on the premises of a pharmacy, or does not already have a sink with running water, refrigerator,
and telephone.
29. Estimate the actual statewide compliance costs of the proposed rules on individuals (regulated individuals or
the public). Include the costs of education, training, application fees, examination fees, license fees, new
equipment, supplies, labor, accounting, or recordkeeping.
The department does not expect the proposed rules to result in any additional educational costs, training, application
fees, examination fees, license fees, new equipment, supplies, labor, accounting, or record keeping on regulated
individuals or the public.
A. How many and what category of individuals will be affected by the rules?
There are 17,266 pharmacists and 1,714 interns in Michigan. Pharmacists, interns, preceptors and the public will be
affected by the rules, but the department does not expect any additional costs to these individuals.
B. What qualitative and quantitative impact do the proposed changes in rules have on these individuals?
MCL 24.245(3)